Results 171 to 180 of about 26,125 (257)

A potent Gc neutralizing antibody reveals architecture-dependent bispecific protection against SFTSV. [PDF]

Emerg Microbes Infect
Lu H, Li L, Zhang N, Liu Y, Liu B, Sun Y, Zhang J, Liu S, Luo J, Liao J, Lv K, Yue X, Xu M, Zhao J, Wu X, Chen X, Tao C, Guo Y, Zhang Z, Wang M, Chen YQ.   +20 more
europepmc   +1 more source

Salvage Therapy With Inotuzumab Ozogamicin in Relapsed/Refractory B‐ALL After CAR‐T Therapy and HSCT: A Case Series

Cancer Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background Although inotuzumab ozogamicin (InO) has been approved as an effective agent for patients with refractory/relapsed (r/r) B‐cell acute lymphoblastic leukemia (B‐ALL), data in the context of post chimeric antigen receptor (CAR)‐T cell therapy and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) relapse are lacking.
Honghu Li, Luxin Yang, Lizhen Liu, Xiaoyu Lai, Lixia Zhu, Kui Zhao, Qian Luo, He Huang, Yi Luo   +8 more
wiley   +1 more source

Bispecific single-domain antibody (VHH) fused with human IgG1 Fc with dual specificity effectively neutralize Naja Kaouthia venom. [PDF]

PLoS Negl Trop Dis
Pothisamutyothin K, Sathorn S, Boonmee R, Thaveekarn W, Arunmanee W.   +4 more
europepmc   +1 more source

Targeting T-Cells for Cancer Treatment: Current Clinical Strategies and Challenges. [PDF]

Biomedicines
Rotte A, Sopjani M, Bhandaru M.
europepmc   +1 more source

Immune, molecular and genetic profiles of gastric signet ring cell carcinoma: Recent progress and future challenges

International Journal of Cancer, Volume 159, Issue 1, Page 11-29, 1 July 2026.
Abstract Gastric signet ring cell carcinoma (GSRCC) is a special type of gastric cancer common in young women. Diffuse gastric cancer (DGC) begins with intramucosal lesions comprising differentiated GSRCC cells. Genetically, GSRCC and DGC are clonally identical, with their morphology influenced by extracellular Wnt signaling.
Qian Wang, Shuai Zhou, Xiongchao Fang, Xianli He, Gang Wang, Nan Wang   +5 more
wiley   +1 more source

Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas. [PDF]

J Hematol Oncol
Munir M, Sayed A, Lee DH, Awan F, Ghazi S, Kim J, Addison D, Epperla N.   +7 more
europepmc   +1 more source

Non-factor Therapies in Hemophilia: Mechanisms, Clinical Evidence, Patient Management, and Future Perspectives. [PDF]

Adv Ther
Nakajima Y, Nogami K.
europepmc   +1 more source

Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review

Journal of Diabetes, Volume 18, Issue 7, July 2026.
Clonal hematopoiesis (CH), driven by obesity‐ and aging‐related inflammation, may be causally associated with an increased risk of Type 2 diabetes through the inflammation–insulin resistance pathway. By exacerbating systemic inflammation, CH may also contribute to the development of macrovascular and microvascular complications in patients with Type 2 ...
Jian‐Jun Liu, Sylvia Liu, Resham L. Gurung, Su Chi Lim, Rajkumar Dorajoo   +4 more
wiley   +1 more source

Clinical tumor lysis syndrome associated with elranatamab in relapsed multiple myeloma: a case report [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Milanesio M, Olmedo J, Caeiro G, Basquiera AL.   +3 more
europepmc   +1 more source